Regional News Archives - Page 78 of 190 - Journal for Clinical Studies

Current Edition

Regional News

Aspen closes in on Africa license for Johnson & Johnson’s COVID-19 vaccine

One of Johnson & Johnson’s long-held pandemic manufacturing partners just made headway in its quest to license the company’s shot in Africa. Aspen Pharmacare on ...

1 December 2021 Regional News Africa | Aspen Pharmacare

Continue Reading →

Regional News

GSK’s ViiV looks to future of injectable HIV treatment as long-acting PrEP decision looms

The future of ViiV Healthcare's HIV business is injectable. By 2026, the majority-GlaxoSmithKline-owned joint venture expects long-acting regimens to generate around...

1 December 2021 Regional News Cabenuva | drug sales

Continue Reading →

Regional News

Bristol Myers Squibb’s next-gen autoimmune med starts high-stakes FDA review amid classwide JAK scrutiny

After the FDA slapped an updated safety warning on marketed oral JAK inhibitors for inflammatory diseases, market watchers have started worrying about other candidate...

1 December 2021 Regional News Autoimmune Diseases | Bristol Myers Squibb

Continue Reading →

Regional News

Amgen’s Otezla, Repatha and biosimilars put on notice, with challenging years ahead

Some of Amgen’s key businesses are drawing concerns as competition looms. Amgen’s 2022 sales could be about $26.3 billion, or $700 million lower than industry watche...

24 November 2021 Regional News Aimovig | Amgen Repatha

Continue Reading →

Regional News

Sagent Pharmaceuticals recalls injectable seizure med thanks to familiar packaging glitch

A familiar packaging snafu has led to another recall at Nichi-Iko Group's Sagent Pharmaceuticals. The Illinois-based manufacturer is recalling four lots of injectabl...

24 November 2021 Regional News drug recall | packaging

Continue Reading →

Regional News

Novartis may have a buyer for $21B generics unit Sandoz

Amid the industrywide push by Big Pharmas to spin off their generics and consumer businesses, Novartis may be on the verge of separating itself from Sandoz. Swedish-...

24 November 2021 Regional News divestment | generics

Continue Reading →

Regional News

AstraZeneca CEO questions mRNA vaccine superiority, raising theory that his company’s shot offers longer-lasting protection

AstraZeneca’s chief executive Pascal Soriot is challenging the notion that his company's vaccine is inferior to the mRNA vaccines from Moderna and Pfizer. In fact, h...

24 November 2021 Regional News AstraZeneca | BioNTech

Continue Reading →

Regional News

ARIA side effects surface in 40% of patients on Biogen’s Alzheimer’s drug Aduhelm

Biogen's Alzheimer's disease drug Aduhelm has endured a headache of a launch, largely due to lingering questions about its true clinical benefit and how the drug won ...

24 November 2021 Regional News Aduhelm (aducanumab) | Alzheimer's

Continue Reading →

Regional News

Pfizer to become $100B behemoth next year thanks to COVID-19 drug and vaccine

The COVID-19 pandemic is creating a $100 billion pharma goliath. Pfizer’s revenue could reach $101.3 billion in 2022, with major contributions coming from the compan...

24 November 2021 Regional News antiviral | BioNTech

Continue Reading →

Regional News

Eli Lilly and Boehringer Ingelheim’s Jardiance stays on its heart failure winning streak⁠—this time in acute patients

Three months after earning an approval to treat chronic heart failure with their SGLT2 inhibitor Jardiance, Eli Lilly and Boehringer Ingelheim have posted new data th...

17 November 2021 Regional News acute heart failure | Boehringer Ingelheim

Continue Reading →